Latest Fresenius News & Updates

See the latest news and media coverage for Fresenius. We track all announcements, press releases, and industry mentions in real time, all in one place.

Fresenius

Healthcare products and private hospital services group

fresenius.com

Headquarters: Bad Homburg, Germany
Company type: Public company
Number of employees: 10,000+
Industry: Pharmaceuticals

Last updated October 25

Latest news about Fresenius

In short: Fresenius raised its 2026 earnings outlook, completed the mAbxience buyout and changed Kabi leadership.

Company announcements

October 15 Fresenius

Fresenius appoints new leadership for strategy execution

Marc-Alexander Mahl and Sara Hennicken assume new roles, replacing Pierluigi Antonelli. This change supports sustainable value creation through innovation-led growth.

October 1 Fresenius

Fresenius acquires remaining mAbxience stake for up to €750 million

The deal grants full ownership of the biosimilars platform, expected to be immediately accretive to core earnings per share starting September 30.

September 25 Fresenius

Fresenius expands European production capacity

It opened new IV lines in Poland and Italy with €54 million investment to strengthen healthcare supply chain resilience across the region.

August 20 Fresenius

Fresenius sells Fresenius Medical Care shares to raise capital

The company sold 7.8 million shares for €300 million to reduce debt and fund growth platforms under its transformation strategy.

Media coverage

October 25 Ad Hoc News

Fresenius completes acquisition of mAbxience

The Fresenius share costs 45.96 euros in weekend trading on October 25, 2026. That is 0.30 percent less than the 46.10 euro Xetra closing price. Fresenius SE & Co. KGaA completed on...

October 20 Seeking Alpha

DaVita, Fresenius drop as HHS seeks dialysis market reforms (DVA:NYSE)

DaVita (DVA) stock and Fresenius Medical Care (FMS) stock drops as Trump administration plans...

October 15 Ad Hoc News

Fresenius share trades above Xetra closing price ahead of quarterly report

Fresenius reports €5,864 million in revenue and a higher forecast. The Fresenius share costs €43.83 on 15.10.2026, 0.62 percent above the Xetra closing price. Fresenius acquires on 01.10.2026...

September 30 Ad Hoc News

Fresenius stock after-hours at EUR 44.75: plus 1.24 percent

Fresenius' investor-relations page reports second-quarter 2026 revenue of EUR 5,864 million, up 6 percent organically, and operating income of EUR 719 million, up 10 percent...

Never miss news about Fresenius

Track Fresenius and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Fresenius competitors & trending companies

Browse news for competitors to Fresenius and other trending companies.